PharmAthene, Inc. (PIP) Tops Q1 Loss Views
Tweet
Share
E-mailGet Alerts PIP Hot Sheet
Price: $0.65 --0%
Financial Fact:
Research and development: 1.24M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Research and development: 1.24M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
PharmAthene, Inc. (NYSE: PIP) reported Q1 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $6.15 million versus the consensus estimate of $4.64 million.
For earnings history and earnings-related data on PharmAthene, Inc. (PIP) click here.
For earnings history and earnings-related data on PharmAthene, Inc. (PIP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Compass Point Reiterates Buy Rating on WhiteFiber Inc (WYFI)
- Pluralsight (PS) Reports Q2 EPS of $0.14
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
